Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response
- PMID: 34607878
- PMCID: PMC8500482
- DOI: 10.1158/1940-6207.CAPR-21-0257
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response
Comment on
-
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?Cancer Prev Res (Phila). 2021 Mar;14(3):373-382. doi: 10.1158/1940-6207.CAPR-20-0426. Epub 2020 Nov 3. Cancer Prev Res (Phila). 2021. PMID: 33148677 Free PMC article.
-
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Letter.Cancer Prev Res (Phila). 2021 Oct;14(10):973-974. doi: 10.1158/1940-6207.CAPR-21-0233. Cancer Prev Res (Phila). 2021. PMID: 34607877 Free PMC article. No abstract available.
References
-
- Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. Management of patients with increased risk for familial pancreatic cancer: updated ecommendations from the International Cancer of the Pancreas Screening (CAPS) onsortium. Gut 2020;69(1):7–17. doi: 10.1136/gutjnl-2019-319352. Epub 2019 Oct 31. - DOI - PMC - PubMed
-
- Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, Lilyquist J, Na J, Moore R, Antwi SO, Bamlet WR, Chaffee KG, DiCarlo J, Wu Z, Samara R, Kasi PM, McWilliams RR, Petersen GM, Couch FJ. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. JAMA. 2018. June 19;319(23):2401–2409. doi: 10.1001/jama.2018.6228. PMID: 29922827; PMCID: PMC6092184. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical